NCT03218891

Brief Summary

The purpose of this study is to evaluate the safety and feasibility of cardiovascular rehabilitation in Patients with refractory angina, evaluate the effect of cardiovascular rehabilitation in patients with angina Refractory, by maximal oxygen consumption (VO2max) and global myocardial ischemic load by Stress Echocardiography; To evaluate the presence of myocardial injury, caused by physical stress, through ultra-sensitive troponin after sessions of aerobic physical activity, evaluating the behavior during the training period; To evaluate the effect of rehabilitation on the modulation of sympathetic activity and inflammation, muscular blood flow and lipid metabolism; To evaluate of the effect of rehabilitation on ventricular function through Stress echocardiography; Detection of ischemic episodes and arrhythmias identified during the Rehabilitation sessions through external cardiac monitoring (telemetry); Evaluate the quality of life assessment through the SF-36 questionnaire, Canadian Cardiovascular Society, the number of symptomatic episodes of ischemia, daily sublingual nitrate intake.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
72

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jan 2016

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2016

Completed
1.4 years until next milestone

First Submitted

Initial submission to the registry

June 5, 2017

Completed
1 month until next milestone

First Posted

Study publicly available on registry

July 17, 2017

Completed
3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 28, 2020

Completed
1.5 years until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2022

Completed
Last Updated

February 11, 2022

Status Verified

March 1, 2020

Enrollment Period

4.6 years

First QC Date

June 5, 2017

Last Update Submit

February 10, 2022

Conditions

Keywords

Refractory AnginaRehabilitation

Outcome Measures

Primary Outcomes (4)

  • Cardiovascular rehabilitation in patients with refractory angina is safe;

    Evaluated number of patients who have any kind of cardiovascular event during rehabilitation, as well as number of sore throat during the sessions.

    3 months of rehabilitation

  • Cardiovascular rehabilitation in patients with refractory angina is efficient;

    Evaluated number of sore throat during the sessions.

    3 months of rehabilitation

  • Improve the maximal oxygen consumption

    Improvement of Maximal oxygen uptake (VO2max)

    3 months of rehabilitation

  • Improve the global myocardial ischemic load

    Reduction of myocardial ischemia, evidenced by improvement of the standard by effort echocardiography

    3 months of rehabilitation

Secondary Outcomes (8)

  • Reduction of myocardial injury caused by physical stress

    3 months of rehabilitation

  • Rehabilitation will modulate sympathetic activity

    3 months of rehabilitation

  • Improvement of ventricular function

    3 months of rehabilitation

  • Improvement of the quality of life

    3 months of rehabilitation

  • Rehabilitation will increase muscle blood flow

    3 months of rehabilitation

  • +3 more secondary outcomes

Study Arms (4)

Clinical treatment physical training

EXPERIMENTAL

Patients with optimized clinical treatment group that will do physical training for 12 weeks. They will do the tests in moment 1 and after 3 mounths. The intervention is the Cardiac Rehabilitation.

Behavioral: Cardiac Rehabilitation

Optimized clinical treatment

NO INTERVENTION

Patients with optimized clinical treatment group that will not do physical training.They will do the tests in moment 1 and after 3 mounths.

Coronary insufficiency without angina

NO INTERVENTION

Group with coronary insufficiency without angina and will not do physical training. They will do the tests only one moment.

Normal healthy subjects

NO INTERVENTION

Group normal healthy subjects, without coronary injuries, diabetes, hypertension and another chronic disease. These group have be sedentary and will not do physical training. They will do the tests only one moment.

Interventions

The physical training program will start shortly after the initial exams have been completed. The physical training protocol will consist of a 12-week duration, with a frequency of 3 weekly sessions of 60 minutes duration each. The intensity will be prescribed from the echocardiogram with effort and cardiopulmonary test. All sessions will be monitored by telemetry and will be distributed as follows: * 5 minutes warm up * 30 to 40 minutes of aerobic exercise (treadmill). The training intensity will be prescribed individually, based on the results of the test results; * 10 minutes of localized exercises; * 5 minutes of relaxation.

Clinical treatment physical training

Eligibility Criteria

Age45 Years - 75 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Stable angina functional class II to IV according to the classification of Canadian Cardiovascular Society (CCS) 39, or limiting angina in Perception of the patient;
  • Documented myocardial ischemia by imaging method;
  • Patients not eligible for myocardial revascularization procedures surgical conventional, due to the unfavorable anatomy;
  • Signature of the Free and Informed Consent Form.

You may not qualify if:

  • Patients with definitive pacemaker or implantable cardioverter defibrillator (ICD);
  • Patients with non-sinus heart rhythm;
  • Patients with complete intraventricular block;
  • Acute coronary syndrome (myocardial infarction or unstable angina) or previous procedures for myocardial revascularization (angioplasty / surgery) less than 3 months;
  • Functional impossibility (orthopedic, rheumatic, neurological, or otherwise) or social for participation in the Rehabilitation Program;
  • Classification of risk for American Heart Association class D physical training (unstable ischemia, stenosis or severe or symptomatic valve insufficiency, congenital heart disease, decompensated heart failure, uncontrolled arrhythmias and other conditions that may be aggravated by exercise).
  • Group 3
  • Patients with coronary insufficiency without angina;
  • Signature of the Free and Informed Consent Form.
  • Group 4
  • Signature of the Free and Informed Consent Form;
  • Healthy;
  • Non-smokers;
  • Sedentary

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Instituto Israelita de Ensino e Pesquisa Albert Einstein 's (IIEP)

São Paulo, 05652-000, Brazil

Location

Related Publications (1)

  • de Assumpcao CRA, do Prado DML, Jordao CP, Dourado LOC, Vieira MLC, Montenegro CGSP, Negrao CE, Gowdak LHW, De Matos LDNJ. Cardiopulmonary exercise test in patients with refractory angina: functional and ischemic evaluation. Clinics (Sao Paulo). 2022 Feb 5;77:100003. doi: 10.1016/j.clinsp.2021.100003. eCollection 2022.

MeSH Terms

Conditions

Angina Pectoris

Interventions

Cardiac Rehabilitation

Condition Hierarchy (Ancestors)

Myocardial IschemiaHeart DiseasesCardiovascular DiseasesVascular DiseasesChest PainPainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

RehabilitationAftercareContinuity of Patient CarePatient CareTherapeuticsHealth ServicesHealth Care Facilities Workforce and Services

Study Officials

  • Luciana Janot de Matos, Dra

    Hospital Israelita Albert Einstein

    PRINCIPAL INVESTIGATOR
  • Luciana Janot de Matos, Dra

    InCor Heart Institute

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: 1. Optimized clinical treatment group + physical training for 12 weeks (TF); 2. optimized clinical treatment group (CT); 3. Group with coronary insufficiency without angina (CD); 4. Group normal healthy subjects
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 5, 2017

First Posted

July 17, 2017

Study Start

January 1, 2016

Primary Completion

July 28, 2020

Study Completion

February 1, 2022

Last Updated

February 11, 2022

Record last verified: 2020-03

Data Sharing

IPD Sharing
Will not share

Locations